Literature DB >> 17977268

Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations.

Shigeki Yamada1, Yasushi Takagi, Kazuhiko Nozaki, Ken-ichiro Kikuta, Nobuo Hashimoto.   

Abstract

OBJECT: The aim of this study was to identify the natural history of untreated cerebral arteriovenous malformations (AVMs) and the risk factors for subsequent hemorrhage after an initial AVM diagnosis.
METHODS: The authors studied 305 consecutive patients with AVMs at the Kyoto University Hospital between 1983 and 2005. These patients were followed up until the first subsequent hemorrhage, the start of any treatment, or the end of 2005. Possible risk factors that were investigated included age at initial diagnosis, sex, type of initial presentation, size and location of the AVM nidus, and the venous drainage pattern. Subsequent hemorrhage occurred in 26 patients from the hemorrhagic group during 380 patient-years, and in 16 patients from the nonhemorrhagic group during 512 patient-years.
RESULTS: The annual bleeding rate in the hemorrhagic group was 6.84% after the initial hemorrhage; however, that rate decreased in the first 5 years (15.42% in the first year, 5.32% in the subsequent 4 years, and 1.72% in more than 5 years). In the nonhemorrhagic group (annual bleeding rate of 3.12%), the patients initially presenting with headaches (annual bleeding rate of 6.48%) or asymptomatic presentations (annual bleeding rate of 6.44%) had a higher risk for subsequent hemorrhage. Conversely, those patients presenting with seizures (annual bleeding rate of 2.20%) or neurological deficits (annual bleeding rate of 1.73%) had a lower risk. A significantly increased risk (p < 0.05) of rebleeding was found among children (hazard ratio [HR] = 2.69), females (HR = 2.93), or patients with deep-seated AVMs (HR = 3.07).
CONCLUSIONS: Children, females, and patients with deep-seated AVMs had a threefold increased risk of rebleeding after an initial cerebral AVM. This increased risk was highest in the first year after the initial hemorrhage, and thereafter gradually decreased.

Entities:  

Mesh:

Year:  2007        PMID: 17977268     DOI: 10.3171/JNS-07/11/0965

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  30 in total

1.  Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk.

Authors:  X Lv; Z Wu; C Jiang; Y Li; X Yang; Y Zhang; M Lv; N Zhang
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

2.  Spontaneous Thrombosis of a Ruptured Brain Arteriovenous Malformation: The Argument for Early Conservative Management.

Authors:  Nitin Goyal; Daniel Hoit; Lucas Elijovich
Journal:  Interv Neurol       Date:  2015-07

3.  Clinical, radiological profile and outcome in pediatric Spetzler-Martin grades I-III arteriovenous malformations.

Authors:  Anup P Nair; Raj Kumar; Anant Mehrotra; A K Srivastava; Rabi Narayan Sahu; Prakash Nair
Journal:  Childs Nerv Syst       Date:  2012-01-21       Impact factor: 1.475

4.  Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture.

Authors:  Helen Kim; Charles E McCulloch; S Claiborne Johnston; Michael T Lawton; Stephen Sidney; William L Young
Journal:  Am J Epidemiol       Date:  2010-05-14       Impact factor: 4.897

5.  Interest of HYPR flow dynamic MRA for characterization of cerebral arteriovenous malformations: comparison with TRICKS MRA and catheter DSA.

Authors:  Raphaël Dautry; Myriam Edjlali; Pauline Roca; Cécile Rabrait; Yijing Wu; Kevin Johnson; Olivier Wieben; Denis Trystram; Christine Rodriguez-Régent; Fawaz Alshareef; Patrick Turski; Jean-François Meder; Olivier Naggara; Catherine Oppenheim
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

6.  Follow-Up MRI for Small Brain AVMs Treated by Radiosurgery: Is Gadolinium Really Necessary?

Authors:  X Leclerc; O Guillaud; N Reyns; J Hodel; O Outteryck; F Bala; N Bricout; M Bretzner; N Ramdane; J-P Pruvo; L Hacein-Bey; G Kuchcinski
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-06       Impact factor: 3.825

Review 7.  The role of microsurgical resection and radiosurgery for cerebral arteriovenous malformations.

Authors:  Joseph Serrone; Mario Zuccarello
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Oct-Dec

8.  Curative glubran 2 embolization of cerebral arteriovenous malformations patient selection and initial results.

Authors:  Jie Liu; Ming Lv; Xianli Lv; Hongwei He; Aihua Liu; Zenghui Qian; Youxiang Li
Journal:  Interv Neuroradiol       Date:  2014-12-05       Impact factor: 1.610

Review 9.  Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations.

Authors:  W Caleb Rutledge; Nerissa U Ko; Michael T Lawton; Helen Kim
Journal:  Transl Stroke Res       Date:  2014-06-15       Impact factor: 6.829

10.  Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population.

Authors:  Rodney A Gabriel; Helen Kim; Stephen Sidney; Charles E McCulloch; Vineeta Singh; S Claiborne Johnston; Nerissa U Ko; Achal S Achrol; Jonathan G Zaroff; William L Young
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.